
Acadia Pharmaceuticals Announces Year-End Retirement of R&D Head Elizabeth H.Z. Thompson, Ph.D.
Acadia Pharmaceuticals Plans Year-End Retirement of R&D Chief Elizabeth H.Z. Thompson After Distinguished Career Acadia Pharmaceuticals Inc. has announced that Elizabeth H.Z. Thompson, Ph.D., its Head of Research and Development, plans to retire from her role for personal reasons. The…












